Rubén Andújar-Espinosa

Profesor Asociado en Ciencias de la Salud

Universidad de Murcia

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rubén Andújar-Espinosa is an Associate Professor in Health Sciences at Universidad de Murcia, Spain. His research interests include asthma management, chronic obstructive pulmonary disease, and the role of inflammatory biomarkers in respiratory diseases. His recent publications focus on clinical effectiveness of therapies for severe asthma and the impact of educational interventions on physical activity in patients with chronic respiratory conditions.

Articles (22)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (15)

Francisco José Ruiz-López

Head of Pneumology Service

Hospital Universitario Virgen del Rocío

SPAIN

Rubén Andújar-Espinosa

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: An ORBE II subanalysis

Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

Persons With Chronic Obstructive Pulmonary Disease and High Levels of Activation Improved Their Physical Activity Skills After an Educational Session.

Disease Modification in Asthma: Are We on the Right Way? A Multidisciplinary Expert Delphi Consensus (MODIASTHMA Consensus)

Tezepelumab in Patients With Severe Asthma: Response at 3 Months.

Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD

Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study

Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population.

Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study.

Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases.

Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTY

Calcifediol for Use in Treatment of Respiratory Disease

Treatable traits in the NOVELTY study

The burden of mild asthma

Analysis of response of severe eosinophilic asthmatic patients to benralizumab

Early effectivity of dupilumab in patients with t2 severe asthma: a prospective real-life study.

Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study.

CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia.

Effectiveness of benralizumab in severe eosinophilic asthma under routine clinical practice.

Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort.

Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial.

Collaborators (15)

Francisco José Ruiz-López

Helen Reddel

David B. Price

Rosa Faner

Virginia Perez-Fernandez

Alvar Agusti

Claude Farah

Gary Anderson

JUAN LUIS GARCIA RIVERO

Luis Puente-Maestu

Ian Pavord

José Miguel Rodríguez

Mario DI GIOACCHINO

Matthew Peters

Luís Manuel Entrenas Costa

Make your next move.